Actinium-225 is a therapeutic radioisotope used to deliver targeted radiation that kills cancer cells.

Many report cognitive ailments—such as brain fog and memory loss—well after recovering from the virus, but their causes have remained a mystery.

The Medical Imaging & Technology Alliance praised the move, saying more patients will now have access to potentially lifesaving care.

That includes utilizing the most up-to-date protocols and equipment, among many other things, ASNC President Randall C. Thompson said.

The radiotracer also eliminated the need for invasive tubes and sedation, Mass General specialists reported in a recent experimental study.

The J-PET scanner will enable total-body positron emission tomography machines to be produced five times cheaper than traditional crystal-based technologies, experts said recently.

The college's long-awaited guidance incorporates nearly five years' worth of data gathered from more than 1,600 healthcare facilities.

President and CEO Stephen Merrick said the company is "well on its way" to having dual production and processing pathways for the valuable medical imaging radioisotope.

A single time point 68Ga-PSMA-PET/CT scan also predicts absorbed therapy dosage for at-risk organs, experts recently discovered.

The Office of the Inspector General redacted the organizations' names listed in its advisory opinion, published recently.

The FDA-approved algorithm can ultimately minimize patients' risk of developing secondary cancers later in life, experts said in Radiology: Artificial Intelligence.

New research also revealed that the molecular imaging technique can better diagnose cancer spread compared to conventional CT scanning.